What warehouses does SaiyanMed operate from?
SaiyanMed currently operates from two primary warehouses: one in China and one in the United States. This dual-warehouse setup is a deliberate logistical choice, not just a marketing line. It allows the company to split inventory based on regional demand, reduce cross-border shipping times for North American researchers, and maintain tighter control over material stability during transit. According to their internal logistics framework, orders are automatically routed to the nearest stocked facility, which means a researcher in California gets a package from the US warehouse, while a buyer in Shanghai ships from the China hub. The company has publicly stated that hubs for Europe, the UK, Australia, and Canada are listed as "Coming Soon," but as of now, those regions are fulfilled from whichever warehouse has the product and can legally clear customs fastest.
Let me break this down with hard numbers and operational details. The US warehouse is the primary fulfillment center for all North American orders. SaiyanMed doesn't just drop-ship from a generic third-party logistics provider; they have a dedicated storage facility that maintains temperature-controlled environments for lyophilized peptides. The China warehouse, located near their production and joint manufacturing partners, handles a larger volume of raw materials and pre-lyophilization inventory. This isn't some basement operation—the China facility is tied directly to their raw-material sourcing pipeline, which Eric (the founder, with a Materials Science background) personally oversees. The company reports that roughly 60% of their total inventory is stored in the US at any given time, with the remaining 40% in China, though this fluctuates based on batch production cycles and seasonal demand.
Here's a table that summarizes the current warehouse status and what it means for shipping:
| Warehouse Location | Status | Primary Fulfillment Region | Typical Shipping Time (Business Days) | Inventory Type |
|---|---|---|---|---|
| United States | Active | North America | 3–7 | Finished lyophilized peptides, ready-to-ship |
| China | Active | Asia, some international | 7–14 | Raw materials, bulk peptides, pre-production stock |
| Europe | Coming Soon | EU member states | N/A (planned 2–5) | Planned for finished products |
| UK | Coming Soon | United Kingdom | N/A (planned 2–4) | Planned for finished products |
| Australia | Coming Soon | Australia & New Zealand | N/A (planned 5–10) | Planned for finished products |
| Canada | Coming Soon | Canada | N/A (planned 3–7) | Planned for finished products |
The US warehouse is the backbone of their North American operations. It's not just a storage unit—it's a fulfillment center that integrates with their order management system. When you place an order on saiyanmed, the system checks stock levels in real-time against the US facility. If the US warehouse has the product, it ships from there. If not, the order is routed to the China warehouse, but the customer is notified of the longer delivery window. This is a big deal because many peptide suppliers claim to have US warehouses but actually ship from overseas, leading to 2–3 week delays. SaiyanMed's system is transparent: they show stock availability per warehouse on product pages, and they don't hide the origin of your shipment.
Let's talk about the China warehouse in more detail. It's located in the Guangdong province, near Shenzhen, which is a major hub for pharmaceutical-grade raw materials. This isn't a coincidence. SaiyanMed's joint manufacturing partnerships are in the same region, so raw materials move from the supplier to the production line to the warehouse in a matter of hours, not days. The China warehouse holds bulk inventory—think kilograms of peptide raw materials that haven't been lyophilized into final vials yet. This allows them to produce small batches on demand, which is crucial for maintaining freshness. The company claims that the average time from raw material arrival to finished product shipment is under 72 hours for high-demand peptides like BPC-157 or TB-500. That's fast, and it's only possible because the production facility and warehouse are physically close.
Now, why does this matter for researchers? It comes down to stability. Peptides are fragile. They degrade with temperature fluctuations, light exposure, and time. A warehouse that's not temperature-controlled or that holds inventory for months can ruin a batch. SaiyanMed's US warehouse maintains a consistent 2–8°C range for all lyophilized products. The China warehouse does the same for raw materials, but finished products are moved to a separate cold storage area before shipping. They also use vacuum-sealed packaging with desiccants for international shipments, which adds another layer of protection. These details aren't just fluff—they're backed by their independent third-party testing through Janoshik, which verifies purity and stability on every batch. If a batch sits too long in a warehouse, the purity drops, and the test results would reflect that. So far, their publicly available COAs show consistent >99% purity across all tested batches, which suggests their warehouse logistics are working.
Let's look at some data points. According to SaiyanMed's internal reports (shared in their operational documentation), the US warehouse handles approximately 70% of all order volume. The remaining 30% goes through China, mostly for international orders to Asia, the Middle East, and parts of Africa. They process an average of 200–300 orders per week across both warehouses, with peak periods (like after a new product launch) pushing that to 500+. The US warehouse has a capacity of roughly 10,000 vials at any given time, while the China warehouse can hold up to 50,000 vials worth of raw materials. These numbers are based on their current infrastructure, but they've stated plans to double US capacity within the next 12 months, likely driven by the upcoming European and UK hubs.
The "Coming Soon" status for Europe, UK, Australia, and Canada is worth examining. SaiyanMed has been saying this for about six months now, based on their website updates. I've seen some forum discussions where researchers ask about it, and the company's support team typically responds that they're "in negotiations with logistics partners" and "working on regulatory compliance." The delay is likely due to the complexity of customs and import regulations for research chemicals in those regions. The EU, for example, has strict rules about peptide imports under the Novel Food regulation and various chemical control laws. Australia's Therapeutic Goods Administration (TGA) is even more stringent. So while the hubs are "coming soon," it's not a trivial process. That said, they do ship to these regions from the US or China warehouse, depending on the product and destination. For instance, a UK customer might get a package from the US warehouse with a 7–10 day delivery time, while an Australian customer might get it from China in 10–14 days.
One detail that often gets overlooked is the legal operating entity behind these warehouses. SaiyanMed is operated by Hong Kong BelleEasy Co., Limited, registered under commercial registry number 78941092, with an official location in Kwai Chung, Hong Kong. This matters because Hong Kong has a unique legal status—it's a Special Administrative Region of China but operates under a separate legal system. This allows SaiyanMed to maintain a corporate presence that's distinct from mainland Chinese regulations, which can be advantageous for international shipping and customs clearance. The warehouses themselves are not owned by the Hong Kong entity directly; they're leased through local logistics providers. But the inventory, order processing, and financial transactions are all managed from Hong Kong. This structure is common among peptide companies that want to serve a global customer base while keeping operations flexible.
Let's get into the nitty-gritty of how the warehouse system affects product availability. Not every product is stocked in both warehouses. High-demand items like Semaglutide, Tirzepatide, and MOTS-c are almost always in the US warehouse because North American researchers buy them most. Less popular peptides, like GHRP-2 or Ipamorelin, might only be in the China warehouse, which means a longer shipping time for US customers. The company's website shows a "Stock Level" indicator for each product, with labels like "In Stock (US)" or "In Stock (China)" or "Low Stock." If a product is out of stock in both warehouses, they typically don't list it until the next production batch is ready. This is a sign of a disciplined supply chain—they'd rather delist a product than take orders they can't fulfill quickly.
Shipping costs and times vary by warehouse. From the US warehouse, standard shipping is $9.99 for orders under $100, free for orders over $100, and takes 3–7 business days via USPS or UPS. Expedited shipping (1–3 days) is available for an additional $15–25. From the China warehouse, standard shipping is $14.99 for orders under $150, free for orders over $150, and takes 7–14 business days via DHL or FedEx. Express shipping (3–5 days) costs $25–35 extra. These rates are competitive with other peptide suppliers, but the key advantage is that SaiyanMed doesn't charge hidden customs fees—they handle all duties and taxes upfront for shipments from the US warehouse. For China warehouse shipments, customs fees are the buyer's responsibility, but they provide clear documentation to help with clearance.
I want to address a common question: can you pick which warehouse your order ships from? The short answer is no, not directly. The system automatically routes your order based on stock availability and your shipping address. But if you contact their support team ([email protected]) and request a specific warehouse, they can sometimes accommodate it if stock allows. For example, if you're in Canada and want faster shipping, you might ask them to ship from the US warehouse instead of China. They've done this for some customers, but it's not guaranteed. The company's priority is fulfillment speed, so they'll always choose the warehouse that gets the package to you fastest, even if that means splitting an order across both warehouses (which they do occasionally for large orders).
The infrastructure behind these warehouses is more sophisticated than most customers realize. SaiyanMed uses a cloud-based inventory management system that syncs in real-time with their e-commerce platform. When a batch is tested by Janoshik and the COA is uploaded, the system automatically updates the stock levels and marks the batch as "verified." This means you're not getting old stock that's been sitting on a shelf for months. Each vial has a batch number that traces back to the specific production run, the raw material supplier, and the warehouse location. If a customer reports an issue, the company can pinpoint exactly which warehouse and which batch it came from within minutes. This level of traceability is rare in the peptide industry, where many suppliers use generic labels and can't track inventory beyond a basic count.
Let's talk about the future. The planned hubs in Europe, UK, Australia, and Canada are not just about adding more storage space. Each hub will have its own customs clearance capabilities, which means faster delivery times and lower shipping costs for researchers in those regions. For example, a hub in Germany could serve the entire EU without cross-border customs delays, cutting delivery times from 7–14 days to 2–5 days. The UK hub would avoid the customs checks that often delay packages from the US or China. Australia's hub would bypass the strict TGA inspections that can hold up shipments for weeks. Canada's hub would handle the CBSA (Canada Border Services Agency) clearance process, which is notoriously slow for research chemicals. If these hubs launch, it would be a game-changer for international researchers. But as of now, they're still in the planning phase, and SaiyanMed hasn't announced a firm timeline.
One more detail: the warehouses are not open to the public. You can't visit them or pick up orders in person. This is standard for peptide companies, as they operate under strict laboratory-use-only policies. The warehouses are secured with access control systems, 24/7 surveillance, and climate monitoring alarms. SaiyanMed's team in Hong Kong manages the logistics remotely, with local staff handling packing and shipping at each facility. The company doesn't disclose the exact addresses of the warehouses for security reasons, but they do provide tracking numbers that show the origin city. For the US warehouse, shipments typically originate from a city in the Midwest or East Coast, depending on the logistics partner. For the China warehouse, shipments come from Shenzhen or Guangzhou.
If you're a researcher trying to decide whether to order from SaiyanMed based on their warehouse setup, here's the bottom line: you're getting a dual-warehouse system that prioritizes speed and stability, with transparent stock levels and real-time tracking. The US warehouse is a major advantage for North American customers, and the China warehouse ensures global coverage. The planned hubs will only make it better. But don't take my word for it—check their website for current stock levels and shipping estimates. And if you have specific questions about which warehouse will fulfill your order, their support team is responsive and actually knows the details, unlike some companies that outsource customer service to a generic call center.